Ischemic stroke continues to be one of the most challenging diseases in translational neurology. Tissue plasminogen activator (tPA) remains the only approved treatment for acute ischemic stroke, but its use is limited to the first hours after stroke onset due to an increased risk of hemorrhagic tran...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!